Company / Return on Assets (ROA)
ENDRA Life Sciences Inc. Return on Assets (ROA) History
FY2017-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-133.8%
FY2020
5-year range
-136.5% / -74.4%
FY2017-FY2020
Trend
+2.0%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -74.4% to -133.8% over the past 2 years.
Based on SEC 10-K filings.
-133.8% in FY2020 with a 3-year CAGR of -46.0%.
Declined from -74.4% to -133.8% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -46.0pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2020, return on assets (roa) increased 2.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -7.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2020 | -133.8% | +2.0% |
| FY2019 | -136.5% | -83.4% |
| FY2018 | -74.4% | +15.2% |
| FY2017 | -87.8% | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026